Sign In
NewsRadar

RiboTargets

The company is a privately owned biopharmaceutical company with therapeutic interests in anti-infectives and oncology, encompassing antibiotics, AIDS and hepatitis C. The company, which focuses on structure based design, applies its computational screening technology to fast-track drug candidate screening and lead compound identification.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Granta Park
Abington, Cambs  CB1 6GB
United Kingdom
+44 1223 895555
+44 1223 895556
http://www.ribotargets.com
Simon Sturge
+44 1223 895555

Company Facts
Founded:Jul 1997
Founders:
CEO:Simon Sturge
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

  • Ian Kent
  • Jeremy Reffin , Apax Partners
  • Jerry Benjamin
  • Paul Geenen , Senior Partner, Rendex Partners
  • Piet Serrure , AlpInvest Partners N.V. (Formerly NIB Capital Private Equity N.V.)
  • David U'Prichard , CEO, 3-Dimensional Pharmaceuticals

    Key Customers

    Key Business Partners

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    23,898
    Tech investments
    From our Online Data Service
    15,437
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Feb 16€2.0MSatellites
    Feb 16N/ABusiness applications
    Feb 15€19.0MDisplays
    Feb 15€10.0MMedical devices
    Feb 15€6.5MMedical devices
    Feb 15€16.0ME-Commerce
    Feb 15€0.3MOptics & Photonics

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    Jan 2
    Urban Jungle
    urban jungle raises 1m in seed funding to build tech-enabled home ...

    Aug 17
    Komed Health
    komed health closes seed financing round

    Jul 10
    Komed Health
    komed health to be supported by nokia and deutsche telekom

    May 4
    Vivet Therapeutics
    vivet therapeutics raises 37.5 million in series a

    Apr 5
    Fliit
    logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...





    About usContact usLegal Information
    Copyright 1999-2018
    Emerging Technology Research Europe Inc. All rights reserved.